» Articles » PMID: 38291092

CircXRN2 Accelerates Colorectal Cancer Progression Through Regulating MiR-149-5p/MACC1 Axis and EMT

Overview
Journal Sci Rep
Specialty Science
Date 2024 Jan 30
PMID 38291092
Authors
Affiliations
Soon will be listed here.
Abstract

In China, there has been a persistent upward trend in the incidence and mortality rates of colorectal cancer (CRC), with CRC ranking second in incidence and fifth in mortality among all malignant tumors. Although circular RNAs (circRNAs) have been implicated in the progression of various cancers, their specific role in CRC progression remains largely unexplored. The objective of this study was to elucidate the role and underlying mechanisms of circXRN2 in CRC. Differential expression of circXRN2 was identified through whole transcriptome sequencing. The expression levels of circXRN2 and miR-149-5p were quantified in CRC tissues, corresponding adjacent normal tissues, and CRC cell lines using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The stability of circXRN2 was confirmed through RNase R and actinomycin D experiments. The binding interaction between circXRN2 and miR-149-5p was validated through RNA pull-down, RNA immunoprecipitation, and dual-luciferase assays. The biological functions of circXRN2 were assessed through a battery of in vitro experiments, including the CCK-8 assay, EdU assay, scratch assay, Transwell assay, and flow cytometry assay. Additionally, in vivo experiments involving a tumor transplantation model and a liver-lung metastasis model were conducted. The influence of circXRN2 on the expression of epithelial-mesenchymal transition (EMT)-related genes was determined via Western blotting analysis. In CRC tissues and cells, there was an upregulation in the expression levels of both circXRN2 and ENC1, while miR-149-5p exhibited a downregulation in its expression. The overexpression of circXRN2 was found to enhance tumor proliferation and metastasis, as evidenced by results from both in vitro and in vivo experiments. Functionally, circXRN2 exerted its antitumor effect by suppressing cell proliferation, migration, and invasion while also promoting apoptosis. Mechanistically, the dysregulated expression of circXRN2 had an impact on the expression of proteins within the EMT signaling pathway. Our results demonstrated that circXRN2 promoted the proliferation and metastasis of CRC cells through the miR-149-5p/ENC1/EMT axis, suggesting that circXRN2 might serve as a potential therapeutic target and novel biomarker in the progression of CRC.

Citing Articles

CircRNAs in colorectal cancer: potential roles, clinical applications, and natural product-based regulation.

Yang J, Fan Q, Wang Y, Liu Y, Xu X, Liang Y Front Oncol. 2025; 15:1525779.

PMID: 39944836 PMC: 11813906. DOI: 10.3389/fonc.2025.1525779.


The study on circRNA profiling uncovers the regulatory function of the hsa_circ_0059665/miR-602 pathway in breast cancer.

Wu Z, Wu M, Jiang X, Shang F, Li S, Mi Y Sci Rep. 2024; 14(1):20555.

PMID: 39232183 PMC: 11374783. DOI: 10.1038/s41598-024-71505-0.


Roles and mechanisms of circular RNA in respiratory system cancers.

Yang N, Jiao M, Zhang Y, Mo S, Wang L, Liang J Front Oncol. 2024; 14:1430051.

PMID: 39077467 PMC: 11284073. DOI: 10.3389/fonc.2024.1430051.

References
1.
Tan Z, Sun W, Li Y, Jiao X, Zhu M, Zhang J . Current Progress of EMT: A New Direction of Targeted Therapy for Colorectal Cancer with Invasion and Metastasis. Biomolecules. 2022; 12(12). PMC: 9775097. DOI: 10.3390/biom12121723. View

2.
Kok S, Oshima H, Takahashi K, Nakayama M, Murakami K, Ueda H . Malignant subclone drives metastasis of genetically and phenotypically heterogenous cell clusters through fibrotic niche generation. Nat Commun. 2021; 12(1):863. PMC: 7870854. DOI: 10.1038/s41467-021-21160-0. View

3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

4.
Smith R, Fedewa S, Siegel R . Early colorectal cancer detection-Current and evolving challenges in evidence, guidelines, policy, and practices. Adv Cancer Res. 2021; 151:69-107. DOI: 10.1016/bs.acr.2021.03.005. View

5.
Roche J . The Epithelial-to-Mesenchymal Transition in Cancer. Cancers (Basel). 2018; 10(2). PMC: 5836084. DOI: 10.3390/cancers10020052. View